Clin2
NCT07396441Possibly a fitRecruiting

Kelulut honey therapy for juvenile glaucoma

Juvenile Open Angle GlaucomaDry Eye Disease (DED)Interleukin 6Retinal Nerve Fiber Layer ThicknessHbA1c Level

Part of Eyes & vision clinical trials.

This trial tests if adding Kelulut honey to standard treatment can help protect the optic nerve in young people with juvenile open-angle glaucoma. It looks at eye pressure, nerve thickness, and dry eye symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
60 people
Ages
15 years to 40 years
Study type
Interventional

Who can take part

  • Diagnosed with juvenile open-angle glaucoma (JOAG)
  • Between 15 and 40 years old
  • Currently on standard treatment and eye pressure is well-controlled
  • No allergy to honey or honey-based products
  • Not taking other honey, antioxidant, or herbal supplements for the past 3 months
  • No other serious eye or nerve diseases, diabetes, or autoimmune conditions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07279324Not yet recruiting
Kelulut honey eyedrops for dry eye

This trial tests if eyedrops made from Kelulut honey can safely improve dry eye symptoms. If you have dry eye disease, you may be able to join and use the drops three times a day for one month.

Kota Bharu, Kelantan
NCT07273747Recruiting
Kelulut honey for eye allergy and dry eye

This study tests if Kelulut honey eye drops can help people with both allergic conjunctivitis (eye allergies) and dry eye symptoms. If you have been diagnosed with eye allergies and still have bothersome symptoms despite treatment, this trial may offer a natural option to explore.

Kota Bharu, Kelantan
NCT07733388Not yet recruiting
Home exercise program for eye health in glaucoma

This trial tests whether a home-based exercise program can lower eye pressure and protect the optic nerve in people with glaucoma. It is designed for patients whose eye pressure is already controlled by medication.

Kubang Kerian, Kelantan
NCT07777861Recruiting· Phase 2
Testing an eye drop for worsening glaucoma

This study tests an eye drop (G01) for people with primary open-angle glaucoma that is getting worse despite current treatments. It aims to see if G01 can safely slow down or stop the progression of glaucoma.

Beijing, Beijing Municipality
NCT06017362Recruiting· Phase 4
Insulin drops for dry eye in glaucoma patients

This study tests whether insulin eye drops can safely help dry eye in people who also use eye drops for glaucoma. It may offer a new option if you have both conditions and your eye pressure is stable.

Madrid, Madrid
NCT07382453Not yet recruiting· Phase 2
A gel with tiny particles for diabetic dry eye disease

This trial tests a special gel containing small particles that may help repair the eye's surface. It is for people with diabetes who also have severe dry eye symptoms.

Hear when a new Dry Eye Disease (DED) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.